PT - JOURNAL ARTICLE AU - Vinall, Maria ED - Lang, Irene TI - Subgroup Analysis of BENEFiT Trial to Evaluate Effect of Bosentan for Patients with CTEPH DP - 2007 Nov 01 TA - MD Conference Express PG - 14--15 VI - 7 IP - 5 4099 - http://mdc.sagepub.com/content/7/5/14.short 4100 - http://mdc.sagepub.com/content/7/5/14.full AB - This article discusses results of a pre-defined subgroup analysis from the bosentan for inoperable chronic thromboembolic pulmonary hypertension [BENEFiT] trial. The BENEFiT study is the first double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of bosentan for patients with inoperable chronic thromboembolic pulmonary hypertension, one of the leading causes of pulmonary arterial hypertension.